Index by author
Onda, Takeshi
- You have accessOral leukoplakia and oral cancerTakeshi Onda, DDS, PhD, Kamichika Hayashi, DDS, PhD, Akira Katakura, DDS, PhD and Masayuki Takano, DDS, PhDCleveland Clinic Journal of Medicine February 2023, 90 (2) 79-80; DOI: https://doi.org/10.3949/ccjm.90a.22044
A 53-year-old male who had smoked for 36 years was referred by his dentist for worsening vitiligo diagnosed as leukoplakia 3 years earlier.
Snipelisky, David
- You have accessA 50-year-old man presents with shortness of breathKaylee Watson, MD, David Wolinsky, MD, Mauricio Velez, MD and David Snipelisky, MD, FACCCleveland Clinic Journal of Medicine February 2023, 90 (2) 95-101; DOI: https://doi.org/10.3949/ccjm.90a.22021
Red flags included low voltage, normal sinus rhythm, and Q waves on electrocardiography, a history of carpal tunnel syndrome, and evidence of renal dysfunction.
Takano, Masayuki
- You have accessOral leukoplakia and oral cancerTakeshi Onda, DDS, PhD, Kamichika Hayashi, DDS, PhD, Akira Katakura, DDS, PhD and Masayuki Takano, DDS, PhDCleveland Clinic Journal of Medicine February 2023, 90 (2) 79-80; DOI: https://doi.org/10.3949/ccjm.90a.22044
A 53-year-old male who had smoked for 36 years was referred by his dentist for worsening vitiligo diagnosed as leukoplakia 3 years earlier.
Taliercio, Jonathan J.
- You have accessResistant hypertension: A stepwise approachJordana Yahr, DO, George Thomas, MD, Juan Calle, MD and Jonathan J. Taliercio, DOCleveland Clinic Journal of Medicine February 2023, 90 (2) 115-125; DOI: https://doi.org/10.3949/ccjm.90a.22046
The authors review the definition and prevalence of resistant hypertension and its diagnostic workup and management, including lifestyle modifications, drugs, and experimental therapies.
Thomas, George
- You have accessResistant hypertension: A stepwise approachJordana Yahr, DO, George Thomas, MD, Juan Calle, MD and Jonathan J. Taliercio, DOCleveland Clinic Journal of Medicine February 2023, 90 (2) 115-125; DOI: https://doi.org/10.3949/ccjm.90a.22046
The authors review the definition and prevalence of resistant hypertension and its diagnostic workup and management, including lifestyle modifications, drugs, and experimental therapies.
Velez, Mauricio
- You have accessA 50-year-old man presents with shortness of breathKaylee Watson, MD, David Wolinsky, MD, Mauricio Velez, MD and David Snipelisky, MD, FACCCleveland Clinic Journal of Medicine February 2023, 90 (2) 95-101; DOI: https://doi.org/10.3949/ccjm.90a.22021
Red flags included low voltage, normal sinus rhythm, and Q waves on electrocardiography, a history of carpal tunnel syndrome, and evidence of renal dysfunction.
Watson, Kaylee
- You have accessA 50-year-old man presents with shortness of breathKaylee Watson, MD, David Wolinsky, MD, Mauricio Velez, MD and David Snipelisky, MD, FACCCleveland Clinic Journal of Medicine February 2023, 90 (2) 95-101; DOI: https://doi.org/10.3949/ccjm.90a.22021
Red flags included low voltage, normal sinus rhythm, and Q waves on electrocardiography, a history of carpal tunnel syndrome, and evidence of renal dysfunction.
Wolinsky, David
- You have accessA 50-year-old man presents with shortness of breathKaylee Watson, MD, David Wolinsky, MD, Mauricio Velez, MD and David Snipelisky, MD, FACCCleveland Clinic Journal of Medicine February 2023, 90 (2) 95-101; DOI: https://doi.org/10.3949/ccjm.90a.22021
Red flags included low voltage, normal sinus rhythm, and Q waves on electrocardiography, a history of carpal tunnel syndrome, and evidence of renal dysfunction.
Yahr, Jordana
- You have accessResistant hypertension: A stepwise approachJordana Yahr, DO, George Thomas, MD, Juan Calle, MD and Jonathan J. Taliercio, DOCleveland Clinic Journal of Medicine February 2023, 90 (2) 115-125; DOI: https://doi.org/10.3949/ccjm.90a.22046
The authors review the definition and prevalence of resistant hypertension and its diagnostic workup and management, including lifestyle modifications, drugs, and experimental therapies.
Zust, Christopher
- You have accessWhat are the treatment options for myasthenia gravis if first-line agents fail?Christopher Zust, MD and John A. Morren, MDCleveland Clinic Journal of Medicine February 2023, 90 (2) 81-84; DOI: https://doi.org/10.3949/ccjm.90a.22022
From 5% to 20% of patients may have a suboptimal response or prohibitive adverse effects over a period of a few weeks to 3 months.
In this issue
Issue highlights
